DRMA
Dermata Therapeutics Inc
NASDAQ: DRMA · HEALTHCARE · BIOTECHNOLOGY
$1.37
+8.73% today
Updated 2026-04-30
Market cap
$4.99M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-8.16
Dividend yield
—
52W range
$1 – $10
Volume
1.8M
Dermata Therapeutics Inc (DRMA) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-144.2%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-65.2%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-13.1%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-16.8%
2026-03-27
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-27 | $-1.52 | +1.3% | $1.37 | $1.14 | -16.8% |
| 2025-11-14 | $-1.65 | -415.6% | $3.14 | $2.84 | -9.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-1.54 | $-1.52 | +1.3% | — | — |
| 2025-09-30 | $-0.32 | $-1.65 | -415.6% | — | — |
| 2025-06-30 | $-0.44 | $-2.67 | -506.8% | — | — |
| 2025-03-31 | $-0.45 | $-1.25 | -178.1% | — | — |
| 2024-12-31 | $-0.32 | $-0.92 | -187.5% | — | — |
| 2024-09-30 | $-26.40 | $-20.40 | +22.7% | — | — |
| 2024-06-30 | $-3.79 | $-4.18 | -10.3% | — | — |
| 2024-03-31 | $-5.40 | $-7.05 | -30.6% | — | — |
| 2023-12-31 | $-0.78 | $-0.21 | +73.1% | — | — |
| 2023-09-30 | $-0.63 | $-0.54 | +14.3% | — | — |
| 2023-06-30 | $-0.92 | $-0.63 | +31.5% | — | — |
| 2023-03-31 | $-2.65 | $-2.27 | +14.3% | — | — |
Frequently asked questions
Has Dermata Therapeutics Inc beaten earnings estimates?
Dermata Therapeutics Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -144.2% over the last 4 quarters.
How does DRMA stock react to earnings?
DRMA stock has moved an average of -13.1% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.